Why this matters: Daily oral semaglutide offers an alternative to weekly injections Lower cash prices compared to injectables: $149$299/month Available at 70,000+ pharmacies (CVS, Costco) and telehealth platforms like Ro, LifeMD, Weight Watchers, GoodRx, and NovoCare Approved not only for weight loss, but also for reducing cardiovascular risk in adults with obesity Clinical impact: Phase 3 trials showed up to 16.6% average weight loss at 64 weeks Same active ingredient as injectable Wegovy, targeting appetite via GLP-1 pathways Industry perspective: With the global GLP-1 market projected to approach $100B by the 2030s, oral therapies may capture nearly 24% of the market, reshaping access, adherence, and affordability
However, Wegovy 7.2 mg and Mounjaro 15 mg result in an average weight loss of around 20%
Pharmacology & Therapeutics, 2007, 113(3): 546-593
By enhancing angiogenesis it increases oxygen and nutrient delivery to damaged tissues
The current fiscal strategy marks a turning point: from expansion to cost containment
Declines in mitochondrial function are a significant underlying cause of the energy drain associated with aging, and carnitine plays an essential role in increasing energy production